Citi analyst Joanne Wuensch lowered the firm’s price target on Stryker (SYK) to $420 from $455 and keeps a Buy rating on the shares. The firm adjusted ratings and targets in the medical technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results